Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Workowski

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Sexually Transmitted Diseases|June 30, 2010
STD screening of HIV-infected MSM in HIV clinicsKaren W Hoover, Mary Butler, Kimberly Workowski, et al.
The Lancet. Microbe|February 20, 2026
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 studyOnyema Ogbuagu, Aditya Gaur, James H McMahon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women With Human Immunodeficiency VirusAndrew Edmonds, Danielle F Haley, Jessie K Edwards, et al.
The Lancet. HIV|July 14, 2023
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trialOnyema Ogbuagu, Sorana Segal-Maurer, Winai Ratanasuwan, et al.
Lancet (London, England)|September 5, 2017
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trialPaul E Sax, Anton Pozniak, M Luisa Montes, et al.
Sexually Transmitted Diseases|January 24, 2022
Coinfection With Chlamydial and Gonorrheal Infection Among US Adults With Early SyphilisJodie Dionne-Odom, Kimberly Workowski, Charlotte Perlowski, et al.
JAMA Network Open|February 13, 2025
Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment in Adults With Early Syphilis: Secondary Analysis of a Randomized Clinical TrialJodie A Dionne, Chunming Zhu, Jorge Mejia-Galvis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 StudyDavid Wyles, Norbert Bräu, Shyam Kottilil, et al.
The New England Journal of Medicine|September 3, 2025
One Dose versus Three Doses of Benzathine Penicillin G in Early SyphilisEdward W Hook, Jodie A Dionne, Kimberly Workowski, et al.
Hepatology (Baltimore, Md.)|November 9, 2015
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 dataJulius M Wilder, Lennox J Jeffers, Natarajan Ravendhran, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Sexually Transmitted Diseases|June 30, 2010
STD screening of HIV-infected MSM in HIV clinicsKaren W Hoover, Mary Butler, Kimberly Workowski, et al.
The Lancet. Microbe|February 20, 2026
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 studyOnyema Ogbuagu, Aditya Gaur, James H McMahon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women With Human Immunodeficiency VirusAndrew Edmonds, Danielle F Haley, Jessie K Edwards, et al.
The Lancet. HIV|July 14, 2023
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trialOnyema Ogbuagu, Sorana Segal-Maurer, Winai Ratanasuwan, et al.
Lancet (London, England)|September 5, 2017
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trialPaul E Sax, Anton Pozniak, M Luisa Montes, et al.
Sexually Transmitted Diseases|January 24, 2022
Coinfection With Chlamydial and Gonorrheal Infection Among US Adults With Early SyphilisJodie Dionne-Odom, Kimberly Workowski, Charlotte Perlowski, et al.
JAMA Network Open|February 13, 2025
Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment in Adults With Early Syphilis: Secondary Analysis of a Randomized Clinical TrialJodie A Dionne, Chunming Zhu, Jorge Mejia-Galvis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 StudyDavid Wyles, Norbert Bräu, Shyam Kottilil, et al.
The New England Journal of Medicine|September 3, 2025
One Dose versus Three Doses of Benzathine Penicillin G in Early SyphilisEdward W Hook, Jodie A Dionne, Kimberly Workowski, et al.
Hepatology (Baltimore, Md.)|November 9, 2015
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 dataJulius M Wilder, Lennox J Jeffers, Natarajan Ravendhran, et al.
Pageof 6